Suppr超能文献

miRNA-4270-5p 通过靶向 SATB2 抑制肝癌细胞增殖和转移。

microRNA-4270-5p inhibits cancer cell proliferation and metastasis in hepatocellular carcinoma by targeting SATB2.

机构信息

Department of Internal Medicine, Liver and Biliary Disease Hospital of Jilin Province, Changchun, Jilin, China.

Department of Endoscopy Center, The China-Japan Union Hospital of Jilin University Hospital, Changchun, Jilin, China.

出版信息

Hum Cell. 2020 Oct;33(4):1155-1164. doi: 10.1007/s13577-020-00384-0. Epub 2020 Jun 5.

Abstract

Hepatocellular carcinoma (HCC) remains a lethal cancer type for both males and females. MicroRNAs (miRNAs) contribute to the initiation, development and metastasis of cancer. Although several miRNAs have been identified as drivers or suppressors of HCC, the molecular mechanisms of many miRNAs have not been investigated. Currently, we discovered that miR-4270-5p was a significantly downregulated miRNA in HCC. We revealed that miR-4270-5p overexpression inhibited cell proliferation and invasion of HCC cells. The data manifested that miR-4270-5p directly targeted SATB2, a key regulator of epithelial mesenchymal transition (EMT), in HCC cells and reversed the EMT process. The rescue experiments suggested that SATB2 overexpression reversed the biological function of miR-4270-5p in HCC cells. Clinical data indicated that SATB2 expression was negatively correlated with miR-4270-5p levels in HCC patients. Our findings provided potential targets for prognosis and treatment of patients with HCC.

摘要

肝细胞癌(HCC)仍然是男性和女性的致命癌症类型。 microRNAs(miRNAs)参与癌症的发生、发展和转移。尽管已经确定了几种 miRNA 是 HCC 的驱动因子或抑制因子,但许多 miRNA 的分子机制尚未得到研究。目前,我们发现 miR-4270-5p 在 HCC 中显著下调。我们揭示了 miR-4270-5p 的过表达抑制了 HCC 细胞的增殖和侵袭。数据表明,miR-4270-5p 在 HCC 细胞中直接靶向 SATB2,SATB2 是上皮间质转化(EMT)的关键调节因子,并逆转了 EMT 过程。挽救实验表明,SATB2 的过表达逆转了 miR-4270-5p 在 HCC 细胞中的生物学功能。临床数据表明,SATB2 的表达与 HCC 患者 miR-4270-5p 的水平呈负相关。我们的研究结果为 HCC 患者的预后和治疗提供了潜在的靶点。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验